In vivo changes in plasma acute phase protein levels in the rat induced by slow release of IL-1, IL-6 and TNF
1992

Effects of Cytokines on Acute Phase Proteins in Rats

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): E. J. Lewis, A. D. Sedgwick, T. H. P. Hanahoe

Primary Institution: Biology Department, Roche Products Ltd

Hypothesis

The study investigates the effects of interleukin-1, interleukin-6, and tumor necrosis factor on acute phase protein levels in rats through different administration methods.

Conclusion

Continuous release of cytokines from osmotic minipumps is more effective in altering acute phase protein levels than single injections.

Supporting Evidence

  • Continuous release of interleukin-1 induced dose-related changes in plasma levels of acute phase proteins.
  • Interleukin-10 had similar effects but required higher doses.
  • Administration of cytokines via osmotic minipumps showed greater efficacy than single injections.

Takeaway

This study shows that giving cytokines slowly over time helps change certain proteins in the blood that respond to inflammation better than just giving them all at once.

Methodology

Female rats were used, and cytokines were administered either by injection or through osmotic minipumps, with plasma levels of acute phase proteins measured afterward.

Potential Biases

Potential bias in cytokine administration methods and the effects of the implantation procedure on inflammation.

Limitations

The study was limited to a specific strain of rats and the effects may not be generalizable to other species.

Participant Demographics

Female, Allen and Hanbury Hooded strain rats, aged 8-12 weeks and weighing 90-160g.

Statistical Information

P-Value

p<0.05 to p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication